Levels Diagnostics
PrivateLast Round
Series A
Extension
Aug 14, 2024
Est. Valuation
$300M
Total Funding Raised
$60M
Company Overview
Levels Diagnostics is a biotechnology company that develops diagnostic tools specializing in biomarker discovery and clinical studies for infectious diseases as well as liver and kidney diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Levels Diagnostics Comps
Public and private peers based on sector, stage, and business model.
Levels Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Aug 14, 2024 | ||||
| Series A | Apr 20, 2022 | ||||
| Seed | Nov 16, 2020 |
Levels Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Series A, Series A Extension, Seed |
| Shrug Capital | Series A |
| Basecamp Fund | Series A |
| Trust Ventures | Series A |
Levels Diagnostics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Levels Diagnostics's valuation, stock price, and market status.
